nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP3A4—type 2 diabetes mellitus	0.14	0.534	CbGaD
Prasugrel—ALB—type 2 diabetes mellitus	0.122	0.466	CbGaD
Prasugrel—ALB—Gliclazide—type 2 diabetes mellitus	0.0326	0.0629	CbGbCtD
Prasugrel—ALB—Repaglinide—type 2 diabetes mellitus	0.0306	0.0591	CbGbCtD
Prasugrel—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0255	0.0493	CbGbCtD
Prasugrel—ALB—Valsartan—type 2 diabetes mellitus	0.0226	0.0436	CbGbCtD
Prasugrel—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0211	0.0408	CbGbCtD
Prasugrel—ALB—Nateglinide—type 2 diabetes mellitus	0.021	0.0405	CbGbCtD
Prasugrel—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0206	0.0399	CbGbCtD
Prasugrel—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0189	0.0364	CbGbCtD
Prasugrel—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0179	0.0347	CbGbCtD
Prasugrel—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0179	0.0347	CbGbCtD
Prasugrel—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0175	0.0339	CbGbCtD
Prasugrel—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0166	0.032	CbGbCtD
Prasugrel—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.016	0.0309	CbGbCtD
Prasugrel—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0149	0.0288	CbGbCtD
Prasugrel—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0149	0.0288	CbGbCtD
Prasugrel—ALB—Glyburide—type 2 diabetes mellitus	0.0142	0.0274	CbGbCtD
Prasugrel—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0138	0.0266	CbGbCtD
Prasugrel—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0135	0.026	CbGbCtD
Prasugrel—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0133	0.0257	CbGbCtD
Prasugrel—ALB—Losartan—type 2 diabetes mellitus	0.013	0.025	CbGbCtD
Prasugrel—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0122	0.0235	CbGbCtD
Prasugrel—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.012	0.0232	CbGbCtD
Prasugrel—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0113	0.0218	CbGbCtD
Prasugrel—CYP3A4—Glipizide—type 2 diabetes mellitus	0.011	0.0212	CbGbCtD
Prasugrel—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0108	0.0209	CbGbCtD
Prasugrel—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00959	0.0185	CbGbCtD
Prasugrel—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00919	0.0177	CbGbCtD
Prasugrel—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00867	0.0168	CbGbCtD
Prasugrel—CYP2C19—Losartan—type 2 diabetes mellitus	0.0084	0.0162	CbGbCtD
Prasugrel—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00764	0.0147	CbGbCtD
Prasugrel—CYP2C9—Losartan—type 2 diabetes mellitus	0.00699	0.0135	CbGbCtD
Prasugrel—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00657	0.0127	CbGbCtD
Prasugrel—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0063	0.0122	CbGbCtD
Prasugrel—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0063	0.0122	CbGbCtD
Prasugrel—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00596	0.0115	CbGbCtD
Prasugrel—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00444	0.00858	CbGbCtD
Prasugrel—CYP3A4—Losartan—type 2 diabetes mellitus	0.00406	0.00784	CbGbCtD
Prasugrel—P2RY12—artery—type 2 diabetes mellitus	0.00383	0.248	CbGeAlD
Prasugrel—P2RY12—cardiovascular system—type 2 diabetes mellitus	0.00133	0.0864	CbGeAlD
Prasugrel—CES2—islet of Langerhans—type 2 diabetes mellitus	0.00117	0.0762	CbGeAlD
Prasugrel—Clopidogrel—CYP1A2—type 2 diabetes mellitus	0.00115	0.602	CrCbGaD
Prasugrel—CES2—retina—type 2 diabetes mellitus	0.001	0.0651	CbGeAlD
Prasugrel—CES2—nephron tubule—type 2 diabetes mellitus	0.000944	0.0613	CbGeAlD
Prasugrel—CES2—cardiovascular system—type 2 diabetes mellitus	0.000848	0.0551	CbGeAlD
Prasugrel—CES2—kidney—type 2 diabetes mellitus	0.00083	0.0539	CbGeAlD
Prasugrel—CES2—pancreas—type 2 diabetes mellitus	0.000824	0.0535	CbGeAlD
Prasugrel—CES2—cortex of kidney—type 2 diabetes mellitus	0.000808	0.0525	CbGeAlD
Prasugrel—Clopidogrel—CYP3A4—type 2 diabetes mellitus	0.000762	0.398	CrCbGaD
Prasugrel—CES2—adipose tissue—type 2 diabetes mellitus	0.000748	0.0486	CbGeAlD
Prasugrel—CES2—liver—type 2 diabetes mellitus	0.000525	0.0341	CbGeAlD
Prasugrel—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000341	0.0221	CbGeAlD
Prasugrel—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000306	0.0199	CbGeAlD
Prasugrel—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000303	0.0197	CbGeAlD
Prasugrel—ALB—liver—type 2 diabetes mellitus	0.0003	0.0195	CbGeAlD
Prasugrel—CYP2B6—kidney—type 2 diabetes mellitus	0.000299	0.0194	CbGeAlD
Prasugrel—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000258	0.00203	CcSEcCtD
Prasugrel—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000257	0.00202	CcSEcCtD
Prasugrel—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000256	0.00201	CcSEcCtD
Prasugrel—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000256	0.00201	CcSEcCtD
Prasugrel—Rash—Nateglinide—type 2 diabetes mellitus	0.000255	0.00201	CcSEcCtD
Prasugrel—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000255	0.002	CcSEcCtD
Prasugrel—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000254	0.002	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000253	0.00199	CcSEcCtD
Prasugrel—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000253	0.00199	CcSEcCtD
Prasugrel—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000253	0.00199	CcSEcCtD
Prasugrel—Anaemia—Glyburide—type 2 diabetes mellitus	0.000253	0.00199	CcSEcCtD
Prasugrel—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.000252	0.00198	CcSEcCtD
Prasugrel—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000251	0.00197	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00025	0.00197	CcSEcCtD
Prasugrel—Angioedema—Glyburide—type 2 diabetes mellitus	0.00025	0.00196	CcSEcCtD
Prasugrel—Nausea—Acarbose—type 2 diabetes mellitus	0.000249	0.00196	CcSEcCtD
Prasugrel—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000248	0.00195	CcSEcCtD
Prasugrel—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000245	0.00192	CcSEcCtD
Prasugrel—CYP2C19—liver—type 2 diabetes mellitus	0.000242	0.0157	CbGeAlD
Prasugrel—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000241	0.00189	CcSEcCtD
Prasugrel—Nausea—Nateglinide—type 2 diabetes mellitus	0.00024	0.00189	CcSEcCtD
Prasugrel—Bradycardia—Metformin—type 2 diabetes mellitus	0.00024	0.00189	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00024	0.00188	CcSEcCtD
Prasugrel—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00024	0.00188	CcSEcCtD
Prasugrel—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000239	0.00188	CcSEcCtD
Prasugrel—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000238	0.00187	CcSEcCtD
Prasugrel—Back pain—Gliclazide—type 2 diabetes mellitus	0.000237	0.00187	CcSEcCtD
Prasugrel—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000237	0.00186	CcSEcCtD
Prasugrel—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000235	0.00185	CcSEcCtD
Prasugrel—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000234	0.00184	CcSEcCtD
Prasugrel—Epistaxis—Irbesartan—type 2 diabetes mellitus	0.000234	0.00184	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000234	0.00184	CcSEcCtD
Prasugrel—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000233	0.00183	CcSEcCtD
Prasugrel—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000233	0.00183	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00183	CcSEcCtD
Prasugrel—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000232	0.00183	CcSEcCtD
Prasugrel—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000232	0.00183	CcSEcCtD
Prasugrel—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000231	0.00182	CcSEcCtD
Prasugrel—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000231	0.00181	CcSEcCtD
Prasugrel—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00179	CcSEcCtD
Prasugrel—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000227	0.00178	CcSEcCtD
Prasugrel—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000227	0.00178	CcSEcCtD
Prasugrel—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000227	0.00178	CcSEcCtD
Prasugrel—CYP3A4—kidney—type 2 diabetes mellitus	0.000226	0.0147	CbGeAlD
Prasugrel—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000224	0.00176	CcSEcCtD
Prasugrel—Rash—Repaglinide—type 2 diabetes mellitus	0.000221	0.00174	CcSEcCtD
Prasugrel—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000221	0.00173	CcSEcCtD
Prasugrel—Eye disorder—Metformin—type 2 diabetes mellitus	0.00022	0.00173	CcSEcCtD
Prasugrel—Epistaxis—Losartan—type 2 diabetes mellitus	0.00022	0.00173	CcSEcCtD
Prasugrel—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.00022	0.00173	CcSEcCtD
Prasugrel—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00022	0.00173	CcSEcCtD
Prasugrel—Headache—Repaglinide—type 2 diabetes mellitus	0.000219	0.00172	CcSEcCtD
Prasugrel—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000219	0.00172	CcSEcCtD
Prasugrel—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000219	0.00172	CcSEcCtD
Prasugrel—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000218	0.00172	CcSEcCtD
Prasugrel—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000218	0.00171	CcSEcCtD
Prasugrel—Back pain—Valsartan—type 2 diabetes mellitus	0.000218	0.00171	CcSEcCtD
Prasugrel—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00171	CcSEcCtD
Prasugrel—Back pain—Orlistat—type 2 diabetes mellitus	0.000216	0.00169	CcSEcCtD
Prasugrel—Cough—Gliclazide—type 2 diabetes mellitus	0.000214	0.00168	CcSEcCtD
Prasugrel—Angiopathy—Metformin—type 2 diabetes mellitus	0.000214	0.00168	CcSEcCtD
Prasugrel—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000214	0.00168	CcSEcCtD
Prasugrel—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000213	0.00167	CcSEcCtD
Prasugrel—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000213	0.00167	CcSEcCtD
Prasugrel—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000212	0.00167	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000211	0.00166	CcSEcCtD
Prasugrel—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.00021	0.00165	CcSEcCtD
Prasugrel—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00164	CcSEcCtD
Prasugrel—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00164	CcSEcCtD
Prasugrel—Hypotension—Glyburide—type 2 diabetes mellitus	0.000208	0.00164	CcSEcCtD
Prasugrel—Nausea—Repaglinide—type 2 diabetes mellitus	0.000208	0.00164	CcSEcCtD
Prasugrel—Asthenia—Glipizide—type 2 diabetes mellitus	0.000208	0.00163	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000208	0.00163	CcSEcCtD
Prasugrel—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000207	0.00163	CcSEcCtD
Prasugrel—Angioedema—Valsartan—type 2 diabetes mellitus	0.000206	0.00162	CcSEcCtD
Prasugrel—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000205	0.00161	CcSEcCtD
Prasugrel—Angioedema—Orlistat—type 2 diabetes mellitus	0.000204	0.0016	CcSEcCtD
Prasugrel—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000202	0.00159	CcSEcCtD
Prasugrel—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000201	0.00158	CcSEcCtD
Prasugrel—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000201	0.00158	CcSEcCtD
Prasugrel—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000199	0.00157	CcSEcCtD
Prasugrel—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000199	0.00157	CcSEcCtD
Prasugrel—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000199	0.00156	CcSEcCtD
Prasugrel—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00156	CcSEcCtD
Prasugrel—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000198	0.00156	CcSEcCtD
Prasugrel—Cough—Valsartan—type 2 diabetes mellitus	0.000197	0.00155	CcSEcCtD
Prasugrel—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000197	0.00155	CcSEcCtD
Prasugrel—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000196	0.00154	CcSEcCtD
Prasugrel—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000195	0.00153	CcSEcCtD
Prasugrel—Cough—Orlistat—type 2 diabetes mellitus	0.000194	0.00153	CcSEcCtD
Prasugrel—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000194	0.00152	CcSEcCtD
Prasugrel—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000193	0.00152	CcSEcCtD
Prasugrel—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00152	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000193	0.00151	CcSEcCtD
Prasugrel—Dizziness—Glipizide—type 2 diabetes mellitus	0.000192	0.00151	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000191	0.0015	CcSEcCtD
Prasugrel—Angiopathy—Losartan—type 2 diabetes mellitus	0.00019	0.00149	CcSEcCtD
Prasugrel—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00019	0.00149	CcSEcCtD
Prasugrel—CYP2B6—liver—type 2 diabetes mellitus	0.000189	0.0123	CbGeAlD
Prasugrel—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000189	0.00148	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000188	0.00148	CcSEcCtD
Prasugrel—CYP2C9—liver—type 2 diabetes mellitus	0.000187	0.0122	CbGeAlD
Prasugrel—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000187	0.00147	CcSEcCtD
Prasugrel—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000185	0.00145	CcSEcCtD
Prasugrel—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00145	CcSEcCtD
Prasugrel—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000184	0.00145	CcSEcCtD
Prasugrel—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000184	0.00144	CcSEcCtD
Prasugrel—Rash—Glipizide—type 2 diabetes mellitus	0.000183	0.00144	CcSEcCtD
Prasugrel—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000183	0.00143	CcSEcCtD
Prasugrel—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000182	0.00143	CcSEcCtD
Prasugrel—Headache—Glipizide—type 2 diabetes mellitus	0.000182	0.00143	CcSEcCtD
Prasugrel—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00018	0.00142	CcSEcCtD
Prasugrel—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000179	0.00141	CcSEcCtD
Prasugrel—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000179	0.00141	CcSEcCtD
Prasugrel—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000179	0.0014	CcSEcCtD
Prasugrel—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000179	0.0014	CcSEcCtD
Prasugrel—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000178	0.0014	CcSEcCtD
Prasugrel—Hypertension—Metformin—type 2 diabetes mellitus	0.000177	0.00139	CcSEcCtD
Prasugrel—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000177	0.00139	CcSEcCtD
Prasugrel—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000177	0.00139	CcSEcCtD
Prasugrel—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000177	0.00139	CcSEcCtD
Prasugrel—Back pain—Losartan—type 2 diabetes mellitus	0.000176	0.00139	CcSEcCtD
Prasugrel—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000175	0.00138	CcSEcCtD
Prasugrel—Headache—Pioglitazone—type 2 diabetes mellitus	0.000174	0.00137	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000174	0.00136	CcSEcCtD
Prasugrel—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000173	0.00136	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000173	0.00136	CcSEcCtD
Prasugrel—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000173	0.00136	CcSEcCtD
Prasugrel—Nausea—Glipizide—type 2 diabetes mellitus	0.000172	0.00135	CcSEcCtD
Prasugrel—Hypotension—Valsartan—type 2 diabetes mellitus	0.000172	0.00135	CcSEcCtD
Prasugrel—Rash—Glimepiride—type 2 diabetes mellitus	0.000171	0.00134	CcSEcCtD
Prasugrel—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00017	0.00134	CcSEcCtD
Prasugrel—Rash—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00134	CcSEcCtD
Prasugrel—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00133	CcSEcCtD
Prasugrel—Headache—Glimepiride—type 2 diabetes mellitus	0.000169	0.00133	CcSEcCtD
Prasugrel—Cough—Irbesartan—type 2 diabetes mellitus	0.000169	0.00133	CcSEcCtD
Prasugrel—Headache—Sitagliptin—type 2 diabetes mellitus	0.000169	0.00133	CcSEcCtD
Prasugrel—Anaemia—Losartan—type 2 diabetes mellitus	0.000169	0.00132	CcSEcCtD
Prasugrel—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000167	0.00131	CcSEcCtD
Prasugrel—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00131	CcSEcCtD
Prasugrel—Angioedema—Losartan—type 2 diabetes mellitus	0.000167	0.00131	CcSEcCtD
Prasugrel—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Prasugrel—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Prasugrel—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Prasugrel—Leukopenia—Losartan—type 2 diabetes mellitus	0.000163	0.00128	CcSEcCtD
Prasugrel—Skin disorder—Metformin—type 2 diabetes mellitus	0.000163	0.00128	CcSEcCtD
Prasugrel—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000162	0.00127	CcSEcCtD
Prasugrel—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000162	0.00127	CcSEcCtD
Prasugrel—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00127	CcSEcCtD
Prasugrel—Nausea—Glimepiride—type 2 diabetes mellitus	0.000161	0.00126	CcSEcCtD
Prasugrel—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00016	0.00126	CcSEcCtD
Prasugrel—Asthenia—Glyburide—type 2 diabetes mellitus	0.00016	0.00126	CcSEcCtD
Prasugrel—Cough—Losartan—type 2 diabetes mellitus	0.000159	0.00125	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000159	0.00125	CcSEcCtD
Prasugrel—Fatigue—Valsartan—type 2 diabetes mellitus	0.000159	0.00125	CcSEcCtD
Prasugrel—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000158	0.00124	CcSEcCtD
Prasugrel—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000158	0.00124	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000157	0.00123	CcSEcCtD
Prasugrel—Fatigue—Orlistat—type 2 diabetes mellitus	0.000157	0.00123	CcSEcCtD
Prasugrel—Hypotension—Metformin—type 2 diabetes mellitus	0.000157	0.00123	CcSEcCtD
Prasugrel—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000155	0.00122	CcSEcCtD
Prasugrel—Rash—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00121	CcSEcCtD
Prasugrel—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00121	CcSEcCtD
Prasugrel—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000154	0.00121	CcSEcCtD
Prasugrel—Headache—Bromocriptine—type 2 diabetes mellitus	0.000153	0.0012	CcSEcCtD
Prasugrel—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000153	0.0012	CcSEcCtD
Prasugrel—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000149	0.00117	CcSEcCtD
Prasugrel—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000149	0.00117	CcSEcCtD
Prasugrel—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000148	0.00116	CcSEcCtD
Prasugrel—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000148	0.00116	CcSEcCtD
Prasugrel—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000146	0.00115	CcSEcCtD
Prasugrel—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000145	0.00114	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000145	0.00114	CcSEcCtD
Prasugrel—Fatigue—Metformin—type 2 diabetes mellitus	0.000144	0.00114	CcSEcCtD
Prasugrel—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000144	0.00113	CcSEcCtD
Prasugrel—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000144	0.00113	CcSEcCtD
Prasugrel—CYP3A4—liver—type 2 diabetes mellitus	0.000143	0.00928	CbGeAlD
Prasugrel—Angioedema—Ramipril—type 2 diabetes mellitus	0.000143	0.00112	CcSEcCtD
Prasugrel—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Prasugrel—Rash—Glyburide—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Prasugrel—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000141	0.0011	CcSEcCtD
Prasugrel—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00014	0.0011	CcSEcCtD
Prasugrel—Headache—Glyburide—type 2 diabetes mellitus	0.00014	0.0011	CcSEcCtD
Prasugrel—Hypotension—Losartan—type 2 diabetes mellitus	0.000139	0.00109	CcSEcCtD
Prasugrel—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000137	0.00108	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000137	0.00107	CcSEcCtD
Prasugrel—Cough—Ramipril—type 2 diabetes mellitus	0.000136	0.00107	CcSEcCtD
Prasugrel—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000136	0.00107	CcSEcCtD
Prasugrel—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000136	0.00107	CcSEcCtD
Prasugrel—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000134	0.00105	CcSEcCtD
Prasugrel—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000133	0.00104	CcSEcCtD
Prasugrel—Nausea—Glyburide—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Prasugrel—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Prasugrel—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Prasugrel—Asthenia—Valsartan—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Prasugrel—Asthenia—Orlistat—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Prasugrel—Fatigue—Losartan—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Prasugrel—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000128	0.001	CcSEcCtD
Prasugrel—Rash—Gliclazide—type 2 diabetes mellitus	0.000126	0.000992	CcSEcCtD
Prasugrel—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000126	0.000992	CcSEcCtD
Prasugrel—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000126	0.000989	CcSEcCtD
Prasugrel—Headache—Gliclazide—type 2 diabetes mellitus	0.000125	0.000986	CcSEcCtD
Prasugrel—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000125	0.000982	CcSEcCtD
Prasugrel—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000125	0.000982	CcSEcCtD
Prasugrel—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000124	0.000978	CcSEcCtD
Prasugrel—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000124	0.000974	CcSEcCtD
Prasugrel—Dizziness—Valsartan—type 2 diabetes mellitus	0.000122	0.000956	CcSEcCtD
Prasugrel—Dizziness—Orlistat—type 2 diabetes mellitus	0.00012	0.000945	CcSEcCtD
Prasugrel—Asthenia—Metformin—type 2 diabetes mellitus	0.00012	0.000945	CcSEcCtD
Prasugrel—Hypotension—Ramipril—type 2 diabetes mellitus	0.000119	0.000937	CcSEcCtD
Prasugrel—Nausea—Gliclazide—type 2 diabetes mellitus	0.000119	0.000935	CcSEcCtD
Prasugrel—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000118	0.000925	CcSEcCtD
Prasugrel—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000117	0.000916	CcSEcCtD
Prasugrel—Rash—Valsartan—type 2 diabetes mellitus	0.000116	0.000912	CcSEcCtD
Prasugrel—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000116	0.000911	CcSEcCtD
Prasugrel—Headache—Valsartan—type 2 diabetes mellitus	0.000115	0.000906	CcSEcCtD
Prasugrel—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000115	0.000901	CcSEcCtD
Prasugrel—Rash—Orlistat—type 2 diabetes mellitus	0.000115	0.000901	CcSEcCtD
Prasugrel—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000115	0.0009	CcSEcCtD
Prasugrel—Headache—Orlistat—type 2 diabetes mellitus	0.000114	0.000895	CcSEcCtD
Prasugrel—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000114	0.000894	CcSEcCtD
Prasugrel—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000113	0.000892	CcSEcCtD
Prasugrel—Dizziness—Metformin—type 2 diabetes mellitus	0.000111	0.000871	CcSEcCtD
Prasugrel—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000866	CcSEcCtD
Prasugrel—Fatigue—Ramipril—type 2 diabetes mellitus	0.00011	0.000865	CcSEcCtD
Prasugrel—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00011	0.000862	CcSEcCtD
Prasugrel—Nausea—Valsartan—type 2 diabetes mellitus	0.000109	0.000859	CcSEcCtD
Prasugrel—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000108	0.00085	CcSEcCtD
Prasugrel—Nausea—Orlistat—type 2 diabetes mellitus	0.000108	0.000849	CcSEcCtD
Prasugrel—Asthenia—Losartan—type 2 diabetes mellitus	0.000107	0.000839	CcSEcCtD
Prasugrel—Rash—Metformin—type 2 diabetes mellitus	0.000106	0.00083	CcSEcCtD
Prasugrel—Dermatitis—Metformin—type 2 diabetes mellitus	0.000106	0.00083	CcSEcCtD
Prasugrel—Headache—Metformin—type 2 diabetes mellitus	0.000105	0.000825	CcSEcCtD
Prasugrel—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000105	0.000822	CcSEcCtD
Prasugrel—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000102	0.0008	CcSEcCtD
Prasugrel—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000101	0.000793	CcSEcCtD
Prasugrel—Rash—Irbesartan—type 2 diabetes mellitus	9.97e-05	0.000784	CcSEcCtD
Prasugrel—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000783	CcSEcCtD
Prasugrel—Nausea—Metformin—type 2 diabetes mellitus	9.95e-05	0.000782	CcSEcCtD
Prasugrel—Headache—Irbesartan—type 2 diabetes mellitus	9.91e-05	0.000779	CcSEcCtD
Prasugrel—Dizziness—Losartan—type 2 diabetes mellitus	9.84e-05	0.000773	CcSEcCtD
Prasugrel—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.4e-05	0.000739	CcSEcCtD
Prasugrel—Nausea—Irbesartan—type 2 diabetes mellitus	9.39e-05	0.000738	CcSEcCtD
Prasugrel—Rash—Losartan—type 2 diabetes mellitus	9.38e-05	0.000737	CcSEcCtD
Prasugrel—Dermatitis—Losartan—type 2 diabetes mellitus	9.38e-05	0.000737	CcSEcCtD
Prasugrel—Headache—Losartan—type 2 diabetes mellitus	9.32e-05	0.000733	CcSEcCtD
Prasugrel—Asthenia—Ramipril—type 2 diabetes mellitus	9.16e-05	0.00072	CcSEcCtD
Prasugrel—Nausea—Losartan—type 2 diabetes mellitus	8.84e-05	0.000695	CcSEcCtD
Prasugrel—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.73e-05	0.000686	CcSEcCtD
Prasugrel—Dizziness—Ramipril—type 2 diabetes mellitus	8.44e-05	0.000663	CcSEcCtD
Prasugrel—Rash—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000632	CcSEcCtD
Prasugrel—Dermatitis—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000632	CcSEcCtD
Prasugrel—Headache—Ramipril—type 2 diabetes mellitus	7.99e-05	0.000628	CcSEcCtD
Prasugrel—Nausea—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000596	CcSEcCtD
Prasugrel—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.33e-06	9.62e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.33e-06	9.62e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.32e-06	9.62e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.32e-06	9.62e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.29e-06	9.58e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SRC—type 2 diabetes mellitus	7.25e-06	9.53e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	7.18e-06	9.43e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	7.18e-06	9.43e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	7.14e-06	9.38e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.14e-06	9.38e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.14e-06	9.38e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.14e-06	9.38e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.06e-06	9.28e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.06e-06	9.27e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GCG—type 2 diabetes mellitus	7.02e-06	9.22e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.02e-06	9.22e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	7e-06	9.19e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	7e-06	9.19e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.98e-06	9.16e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	6.86e-06	9.01e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.82e-06	8.96e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	6.82e-06	8.96e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	6.82e-06	8.96e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	6.82e-06	8.96e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	6.81e-06	8.95e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	6.81e-06	8.95e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	6.81e-06	8.95e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.81e-06	8.95e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.81e-06	8.95e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.81e-06	8.95e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	6.78e-06	8.9e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CTGF—type 2 diabetes mellitus	6.69e-06	8.79e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	6.66e-06	8.74e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	6.63e-06	8.71e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	6.58e-06	8.64e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.54e-06	8.59e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.53e-06	8.58e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.53e-06	8.58e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.51e-06	8.56e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	6.49e-06	8.52e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.48e-06	8.52e-05	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	6.4e-06	8.41e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	6.38e-06	8.38e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	6.38e-06	8.38e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.36e-06	8.35e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.29e-06	8.26e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.29e-06	8.26e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	6.26e-06	8.22e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	6.23e-06	8.19e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.22e-06	8.17e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	6.22e-06	8.17e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	6.22e-06	8.17e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	6.22e-06	8.17e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	6.18e-06	8.12e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.17e-06	8.11e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	6.16e-06	8.09e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	6.16e-06	8.09e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.13e-06	8.06e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	6.12e-06	8.03e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	6.12e-06	8.03e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	6.12e-06	8.03e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.07e-06	7.97e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.07e-06	7.97e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.07e-06	7.97e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	6.07e-06	7.97e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	6.05e-06	7.95e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.05e-06	7.95e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	6.02e-06	7.91e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	6.01e-06	7.89e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6e-06	7.89e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6e-06	7.88e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.98e-06	7.85e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	5.95e-06	7.82e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	5.94e-06	7.8e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	5.91e-06	7.76e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GCG—type 2 diabetes mellitus	5.91e-06	7.76e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.87e-06	7.71e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	5.82e-06	7.65e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	5.77e-06	7.58e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.71e-06	7.5e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	5.61e-06	7.37e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	5.59e-06	7.35e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.59e-06	7.35e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.58e-06	7.33e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.58e-06	7.33e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.58e-06	7.33e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	5.53e-06	7.27e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	5.53e-06	7.27e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	5.51e-06	7.23e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.47e-06	7.19e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.42e-06	7.13e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	5.39e-06	7.09e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	5.39e-06	7.08e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	5.37e-06	7.06e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.37e-06	7.05e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.35e-06	7.03e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.34e-06	7.02e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SRC—type 2 diabetes mellitus	5.31e-06	6.98e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	5.31e-06	6.97e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	5.3e-06	6.97e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	5.3e-06	6.97e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.23e-06	6.87e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	5.17e-06	6.8e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.17e-06	6.79e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.16e-06	6.78e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.16e-06	6.78e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.16e-06	6.78e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.16e-06	6.78e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.1e-06	6.7e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GNB3—type 2 diabetes mellitus	5.09e-06	6.69e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.09e-06	6.69e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	5.07e-06	6.66e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.04e-06	6.63e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.04e-06	6.63e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CAT—type 2 diabetes mellitus	5e-06	6.57e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	4.96e-06	6.51e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.95e-06	6.5e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.92e-06	6.46e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.89e-06	6.43e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—IL6—type 2 diabetes mellitus	4.89e-06	6.42e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	4.86e-06	6.39e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.85e-06	6.38e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.83e-06	6.35e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.83e-06	6.35e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	4.75e-06	6.24e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	4.72e-06	6.2e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	4.71e-06	6.19e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—LPL—type 2 diabetes mellitus	4.64e-06	6.09e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.63e-06	6.09e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.62e-06	6.06e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.6e-06	6.04e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.57e-06	6e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	4.57e-06	6e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.56e-06	5.99e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	4.55e-06	5.98e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	4.54e-06	5.96e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GPX1—type 2 diabetes mellitus	4.52e-06	5.94e-05	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.51e-06	5.92e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	4.49e-06	5.9e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CD36—type 2 diabetes mellitus	4.4e-06	5.79e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.36e-06	5.73e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	4.35e-06	5.71e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.29e-06	5.64e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.24e-06	5.57e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.21e-06	5.53e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.21e-06	5.53e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	4.17e-06	5.48e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.17e-06	5.47e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.17e-06	5.47e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.16e-06	5.47e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.15e-06	5.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.13e-06	5.42e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.1e-06	5.39e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.1e-06	5.39e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.1e-06	5.39e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARA—type 2 diabetes mellitus	4.09e-06	5.38e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.09e-06	5.38e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.07e-06	5.35e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.07e-06	5.35e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.06e-06	5.33e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.02e-06	5.28e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4e-06	5.26e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.97e-06	5.22e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.97e-06	5.21e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.96e-06	5.2e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.95e-06	5.19e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.94e-06	5.18e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.9e-06	5.13e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.9e-06	5.12e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.89e-06	5.1e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.87e-06	5.08e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.84e-06	5.05e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.79e-06	4.98e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.75e-06	4.92e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.71e-06	4.88e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.7e-06	4.86e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.68e-06	4.83e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.68e-06	4.83e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.68e-06	4.83e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.68e-06	4.83e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.61e-06	4.75e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.61e-06	4.74e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.6e-06	4.74e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.58e-06	4.7e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.56e-06	4.68e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	3.56e-06	4.68e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.5e-06	4.6e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.5e-06	4.6e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.49e-06	4.58e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.46e-06	4.54e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.46e-06	4.54e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.45e-06	4.53e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.42e-06	4.49e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PPARG—type 2 diabetes mellitus	3.38e-06	4.45e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.36e-06	4.42e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.35e-06	4.4e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.33e-06	4.37e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.33e-06	4.37e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—INS—type 2 diabetes mellitus	3.32e-06	4.36e-05	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	3.3e-06	4.34e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.25e-06	4.26e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.19e-06	4.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.19e-06	4.19e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.19e-06	4.19e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.18e-06	4.18e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.16e-06	4.15e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.14e-06	4.13e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.04e-06	3.99e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.98e-06	3.91e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.91e-06	3.82e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.91e-06	3.82e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.77e-06	3.64e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.75e-06	3.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.75e-06	3.61e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.74e-06	3.59e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.73e-06	3.59e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.72e-06	3.57e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.7e-06	3.55e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.66e-06	3.5e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.62e-06	3.44e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.61e-06	3.43e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.61e-06	3.43e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.55e-06	3.35e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.5e-06	3.29e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.49e-06	3.27e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.45e-06	3.22e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.44e-06	3.21e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.39e-06	3.14e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.38e-06	3.13e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.38e-06	3.13e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.38e-06	3.12e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.35e-06	3.08e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.25e-06	2.96e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.21e-06	2.9e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	2.86e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.14e-06	2.81e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-06	2.77e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.1e-06	2.76e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.07e-06	2.72e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.83e-06	2.4e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.79e-06	2.35e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.64e-06	2.16e-05	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.59e-06	2.09e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	2.06e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	2.06e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.44e-06	1.89e-05	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.34e-06	1.76e-05	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.2e-06	1.58e-05	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	1.44e-05	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.22e-07	9.49e-06	CbGpPWpGaD
